Studies: Pemetrexed and BSC vs. Placebo and BSCID Trial5122Clinicaltrials.gov identifierNCT00102804DescriptionA phase 3, double-blind, placebocontrolled study of maintenance Pemetrexed and Best Supportive Care versus Best Supportive Care immediately following induction treatment for advanced non-small cell lung cancer. StatusclosedDisease
SponsorEli Lilly and CompanyWorldwide Headquaters 46285 Indianapolis USA Coordinating investigatorNo dataPrincipal investigator
Study nurseNo data |
|